Requires involuntary commitment of certain individuals who have been administered opioid antidotes.
Allows involuntary commitment for certain overdose patients treated with antidotes to pursue treatment and prevent repeat incidents.
Allows involuntary commitment for certain overdose patients treated with antidotes to pursue treatment and prevent repeat incidents.
This bill addresses circumstances in which individuals who have received opioid overdose reversal medication (most commonly naloxone) may be subject to involuntary commitment proceedings. The measure sets rules for temporary or longer-term treatment based on specific criteria following administration of opioid antidotes.
Trigger for Commitment: The bill designates certain conditions under which an individual who has been administered an opioid antidote may be subject to involuntary commitment proceedings. The specific criteria typically involve:
Types of Commitment: The bill outlines the process for:
Evaluation and Protections: Requirements may include:
Treatment Standards: Provisions are expected to specify that individuals receive appropriate treatment for substance use disorders, including addiction treatment services, detoxification if needed, and placement in appropriate treatment facilities or programs.
Roles and Responsibilities: Designates the responsibilities of:
Duration and Review: Timelines for commitment duration, mandatory periodic reviews, and criteria for discharge or transition to voluntary treatment.
Privacy and Compliance: Adheres to existing confidentiality and privacy requirements for individuals’ health and treatment information.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.